garcinia (Garcinia spp.)

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• athletic performance [Insufficient Evidence]
• dyslipidemia [Insufficient Evidence]
• metabolic dysfunction-associated steatotic liver disease [Insufficient Evidence]
• nephrolithiasis [Insufficient Evidence]
• obesity [Insufficient Evidence]
• periodontitis [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

athletic performance

[Insufficient Evidence]

Dose: 250 mg hydroxycitric acid PO qd; Info: standardized extracts typically contain 50-60% hydroxycitric acid

dyslipidemia

[Insufficient Evidence]

Dose: 1000-3450 mg hydroxycitric acid PO qd

metabolic dysfunction-associated steatotic liver disease

[Insufficient Evidence]

Dose: 1875 mg/day PO divided tid; Info: given before meals

nephrolithiasis

[Insufficient Evidence]

Dose: 2070 mg hydroxycitric acid PO qd x6wk; Start: 2070 mg hydroxycitric acid PO q12h x4wk before extracorporeal shock wave lithotripsy

obesity

[Insufficient Evidence]

Dose: 1000-4667 mg/day PO in divided doses; Alt: 500-600 mg PO bid

periodontitis

[Insufficient Evidence]

Dose: apply 2.5 g/100 mL gel topically; Start: 4wk after scaling and root planing; Info: used with tetracycline fibers